TW · Healthcare

Panion & BF Biotech Inc (1760)

Biotechnology

Panion & BF Biotech Inc (1760) is listed on TW in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 1760

P/E ratio

25.00

Panion & BF Biotech Inc (1760) — FAQ

What is 1760's P/E ratio?

The price-to-earnings (P/E) ratio for Panion & BF Biotech Inc (1760) is 25.00 (data as of 2026-05-23).

Does Panion & BF Biotech Inc pay a dividend?

Dividend yield is not available in the current snapshot for Panion & BF Biotech Inc (1760). Check the MyAverix Finance app for the latest dividend data.

What sector is Panion & BF Biotech Inc in?

Panion & BF Biotech Inc (1760) is classified in the Healthcare sector (Biotechnology industry).

What exchange is 1760 listed on?

1760 is listed on TW.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)